カテゴリ： Grand View Research, 世界, 医療/バイオ

プライマリケアPOC診断の世界市場2023-2030：市場規模、シェア、動向分析

■ 英語タイトル：Primary Care POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End-use (Pharmacy & Retail Clinics, Physician Office), By Region, And Segment Forecasts, 2023 - 2030

調査会社Grand View Research社が発行したリサーチレポート（データ管理コード：GRV23NVB035）■ 発行会社/調査会社：Grand View Research
■ 商品コード：GRV23NVB035
■ 発行日：2023年10月23日
■ 調査対象地域：グローバル
■ 産業分野：臨床診断
■ ページ数：192
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[プライマリケアPOC診断の世界市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

プライマリケアPOC診断市場の成長と動向
Grand View Research, Inc.の新しいレポートによると、プライマリケアPOC診断の世界市場規模は2030年までに261億7000万米ドルに達すると予測されており、予測期間中のCAGRは6.5%を記録しています。柔軟で先進的な中核分子ラボは、多くの一般的なターゲットのスクリーニングを病院のレセプションルームや医師のオフィスに移行するために、POC検査の使用を受け入れ、サポートしています。

2014年にAmerican Journal of Clinical Pathologyが実施した研究によると、POC検査は、患者のフォローアップコールと手紙をそれぞれ85.0%と89.0%削減し、フォローアップ訪問を61.0%削減することで、メーカーの臨床業務を改善することがわかりました。また、検査件数は21.0％減少しました。

さらに、1988年臨床検査改善法（CLIA）により免除された検査数の増加が、市場の成長を促進すると予想されます。患者1人当たり約12～15米ドルのコスト削減と約50.0％のフォローアップ検査削減により、研究者やメーカーはますますこれらの検査を推奨するようになっています。しかし、異なる検査法とその使用領域には大きな重複があります。例えば、グルコース測定パネルや迅速国際標準化比検査は、元々は自己検査用でしたが、現在では病院やプライマリ環境で使用されています。

プライマリケアPOC診断市場レポートハイライト

- 2022年の市場シェアは感染症分野が26.4%で最大です。これは、感染症の流行の増加、迅速かつ正確な診断への需要、POC検査の利点に対する意識の高まりによるものです。

- 定期検診の一環として脂質検査を実施する外来患者の増加は、市場における脂質検査の採用率を積極的に高めると予想され、製品別市場全体でも突出した地位を占めています。

- 最終用途の観点では、研究機関やバイオテクノロジー企業による先進的で精度の高いPOC検査キットの共同研究が医院部門を促進する一方、政府のイニシアティブやプライマリ・ケア施設の拡張プロジェクトが非診療所部門を後押しする見込みです。

- 北米のプライマリ・ケアPOC診断市場は、世界の他の地域よりも発展しています。革新的で先進的なPOC診断製品が複数提供されていること、プライマリ在宅医療や補助医療におけるPOC診断に対する認識と需要が高まっていることが、この地域セグメントの原動力となっています。

- 米国市場では、在宅医療、在宅検査、モニタリング機器への患者の関与が増加する傾向にあります。さらに、デジタル化、EHR、遠隔医療、モニタリングデータのウェブ対応ソリューションが米国で加速しており、市場の成長を牽引しています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. プライマリケアPOC診断市場変数・傾向・範囲
第4章. プライマリケアPOC診断の世界市場：製品別予測・傾向分析
第5章. プライマリケアPOC診断の世界市場：エンドユース別予測・傾向分析
第6章. プライマリケアPOC診断の世界市場：地域別予測・傾向分析
第7章. 競争状況

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Primary Care POC Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Primary Care POC Diagnostics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Primary Care POC Diagnostics: Product Estimates & Trend Analysis
4.1. Primary Care POC Diagnostics Market: Key Takeaways
4.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Glucose Testing
4.3.1. Glucose Testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Hb1Ac Testing
4.4.1. Hb1Ac testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. 4.5. Autoimmune Disease
4.5.1. Autoimmune Disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Coagulation
4.6.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Fertility
4.7.1. Fertility market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Infectious Diseases
4.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Cardiac Markers
4.9.1. Cardiac markers market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Thyroid Stimulating Hormone
4.10.1. Thyroid stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Hematology
4.11.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Primary Care Systems
4.12.1. Primary care systems market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Decentralized Clinical Chemistry
4.13.1. Decentralized clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Feces
4.14.1. Feces market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. Lipid Testing
4.15.1. Lipid testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Cancer Markers
4.16.1. Cancer markers market estimates and forecasts, 2018 to 2030 (USD Million)
4.17. Blood Gas/Electrolytes
4.17.1. Blood gas/electrolytes market estimates and forecasts, 2018 to 2030 (USD Million)
4.18. Ambulatory Chemistry
4.18.1. Ambulatory chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.19. Drug Abuse Testing
4.19.1. Drug abuse testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.20. Urinalysis
4.20.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Primary Care POC Diagnostics: End Use Estimates & Trend Analysis
5.1. Primary Care POC Diagnostics Market: Key Takeaways
5.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Pharmacy & Retail Clinics
5.3.1. Pharmacy & Retail Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Physician office
5.4.1. Physician office market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Urgent Care Clinics
5.5.1. Urgent care clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Non-practice Clinics
5.6.1. Non-practice clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Primary Care POC Diagnostics Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. F Hoffmann-La Roche Ltd.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Danaher
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Abbott
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Siemens Healthineers
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. bioMerieux SA
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Abaxis
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. QIAGEN
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Johnson & Johnson Services, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Nova Biomedical
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Instrumentation Laboratory
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Trividia Health, Inc.
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. OraSure Technologies, Inc.
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Quidel Corporation
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Trinity Biotech
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. Sekisui Diagnostics
7.2.15.1. Company overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
7.2.16. BD
7.2.16.1. Company overview
7.2.16.2. Financial performance
7.2.16.3. Product benchmarking
7.2.16.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 North America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 4 North America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 Canada primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 Europe primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 Germany primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 15 UK primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 France primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 France primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 19 Italy primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Spain primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Sweden primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Norway primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 25 Norway primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Denmark primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 China primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 32 China primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Japan primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Japan primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 India primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 36 India primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 Australia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Thailand primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 South Korea primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 44 Latin America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 60 UAE primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 精密医療の世界市場2023-2030：市場規模、シェア、動向分析
  • 世界の医療用チューブ市場2023-2030：市場規模、シェア、動向分析
  • 心臓バイオマーカーの世界市場2023-2030：市場規模、シェア、動向分析
  • PoC診断のアジア太平洋市場2023-2030：市場規模、シェア、動向分析
  • 尿路感染症検査の世界市場2023-2030：市場規模、シェア、動向分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GRV23NVB035 )"プライマリケアPOC診断の世界市場2023-2030：市場規模、シェア、動向分析" (英文：Primary Care POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End-use (Pharmacy & Retail Clinics, Physician Office), By Region, And Segment Forecasts, 2023 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。